Neurocrine Biosciences
NBIX
#1351
Rank
HK$104.51 B
Marketcap
HK$1,032
Share price
4.78%
Change (1 day)
9.98%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of September 2024 : HK$27.48 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are HK$27.48 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31HK$25.39 B37.21%
2022-12-31HK$18.50 B14.52%
2021-12-31HK$16.16 B20.17%
2020-12-31HK$13.44 B32.21%
2019-12-31HK$10.17 B30.78%
2018-12-31HK$7.77 B21.75%
2017-12-31HK$6.38 B125.63%
2016-12-31HK$2.83 B-23.07%
2015-12-31HK$3.67 B95.21%
2014-12-31HK$1.88 B57.17%
2013-12-31HK$1.19 B-21.04%
2012-12-31HK$1.51 B41.35%
2011-12-31HK$1.07 B-4.38%
2010-12-31HK$1.12 B104.69%
2009-12-31HK$0.54 B-39.87%
2008-12-31HK$0.91 B-57.66%
2007-12-31HK$2.15 B-28.83%
2006-12-31HK$3.03 B-19.09%
2005-12-31HK$3.74 B-7.17%
2004-12-31HK$4.03 B-6.2%
2003-12-31HK$4.30 B106.94%
2002-12-31HK$2.07 B-23.03%
2001-12-31HK$2.70 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
HK$22.00 B-19.93%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$140.28 B 410.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$26.55 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$587.85 B 2,038.81%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.115 T 3,957.20%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.706 T 6,108.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$10.00 B-63.58%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.75 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA